0001415889-24-007527.txt : 20240311
0001415889-24-007527.hdr.sgml : 20240311
20240311171732
ACCESSION NUMBER: 0001415889-24-007527
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240308
FILED AS OF DATE: 20240311
DATE AS OF CHANGE: 20240311
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dierks Jeffrey
CENTRAL INDEX KEY: 0001821102
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39450
FILM NUMBER: 24739134
MAIL ADDRESS:
STREET 1: 630 W. GERMANTOWN PIKE
STREET 2: SUITE 215
CITY: PLYMOUTH MEETING
STATE: PA
ZIP: 19462
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Harmony Biosciences Holdings, Inc.
CENTRAL INDEX KEY: 0001802665
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 822279923
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 630 W GERMANTOWN PIKE
STREET 2: SUITE 215
CITY: PLYMOUTH MEETING
STATE: PA
ZIP: 19462
BUSINESS PHONE: (484) 539-9800
MAIL ADDRESS:
STREET 1: 630 W GERMANTOWN PIKE
STREET 2: SUITE 215
CITY: PLYMOUTH MEETING
STATE: PA
ZIP: 19462
4
1
form4-03112024_090322.xml
X0508
4
2024-03-08
0001802665
Harmony Biosciences Holdings, Inc.
HRMY
0001821102
Dierks Jeffrey
C/O HARMONY BIOSCIENCES HOLDINGS, INC.
630 W GERMANTOWN PIKE, SUITE 215
PLYMOUTH MEETING
PA
19462
false
true
false
false
CHIEF COMMERCIAL OFFICER
0
Common Stock
2024-03-08
4
M
0
194
8.22
A
194
D
Common Stock
2024-03-08
4
S
0
194
32
D
0
D
Stock Option
8.22
2024-03-08
4
M
0
100
0
D
2029-10-01
Common Stock
100
2335
D
Stock Option
8.22
2024-03-08
4
M
0
94
0
D
2030-03-04
Common Stock
94
14513
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
These shares were sold in a single transaction at a selling price of $32.00. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The stock option vests in five equal annual installments beginning on October 1, 2019.
The stock option vests in five equal annual installments beginning on March 1, 2021.
/s/ Christian Ulrich, Attorney-in-Fact
2024-03-11